User profiles for Bernard Le Foll

Bernard Le Foll

University of Toronto; Centre for Addiction and Mental Health; Waypoint Centre for Mental …
Verified email at camh.ca
Cited by 16560

Cannabis use and cannabis use disorder

JP Connor, D Stjepanović, B Le Foll, E Hoch… - Nature Reviews …, 2021 - nature.com
Cannabis use disorder (CUD) is an underappreciated risk of using cannabis that affects ~10%
of the 193 million cannabis users worldwide. The individual and public health burdens …

Genetics of dopamine receptors and drug addiction: a comprehensive review

B Le Foll, A Gallo, Y Le Strat, L Lu… - Behavioural …, 2009 - journals.lww.com
Drug dependence is a chronic, relapsing disorder in which compulsive drug-seeking and
drug-taking behaviours persist despite serious negative consequences. Addictive substances, …

[HTML][HTML] Tobacco and nicotine use

B Le Foll, ME Piper, CD Fowler, S Tonstad… - Nature Reviews …, 2022 - nature.com
Tobacco smoking is a major determinant of preventable morbidity and mortality worldwide.
More than a billion people smoke, and without major increases in cessation, at least half will …

Lower-risk cannabis use guidelines: a comprehensive update of evidence and recommendations

…, W Van Den Brink, B Le Foll… - … journal of public …, 2017 - ajph.aphapublications.org
Background. Cannabis use is common in North America, especially among young people,
and is associated with a risk of various acute and chronic adverse health outcomes. Cannabis …

Dopamine D3 receptors expressed by all mesencephalic dopamine neurons

J Diaz, C Pilon, B Le Foll, C Gros, A Triller… - Journal of …, 2000 - Soc Neuroscience
A polyclonal antibody was generated using synthetic peptides designed in a specific sequence
of the rat D 3 receptor (D 3 R). Using transfected cells expressing recombinant D 3 R, but …

Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States

Y Le Strat, C Dubertret, B Le Foll - Journal of affective disorders, 2011 - Elsevier
BACKGROUND: Little is known about the prevalence and comorbidity of Major Depressive
Episode (MDE) during pregnancy in the general population. This study presents nationally …

Psychosocial interventions for cannabis use disorder

…, P Sabioni, J Copeland, B Le Foll… - Cochrane Database …, 2016 - cochranelibrary.com
Background Cannabis use disorder is the most commonly reported illegal substance use
disorder in the general population; although demand for assistance from health services is …

Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence

B Le Foll, SR Goldberg - Journal of Pharmacology and Experimental …, 2005 - ASPET
This review examines the development of cannabinoid CB 1 receptor antagonists as a new
class of therapeutic agents for drug addiction. Abused drugs [alcohol, opiates, Δ 9 -…

[HTML][HTML] Identification of dopamine D1–D3 receptor heteromers: indications for a role of synergistic D1–D3 receptor interactions in the striatum

…, S Ferré, V Casadó, A Cortés, B Le Foll… - Journal of Biological …, 2008 - ASBMB
The function of dopamine D 3 receptors present in the striatum has remained elusive. In the
present study evidence is provided for the existence of dopamine D 1 –D 3 receptor …

[HTML][HTML] Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis

…, KE Khor, M Farrell, A Smith, B Le Foll - …, 2017 - nature.com
Cannabinoids, when co-administered with opioids, may enable reduced opioid doses
without loss of analgesic efficacy (ie, an opioid-sparing effect). The aim of this study was to …